Developing new medications for children to prevent HIV and related infections
Expertise in Development of Pediatric Drug Formulations
['FUNDING_OTHER'] · ADVANCED BIOSCIENCE LABORATORIES, INC. · NIH-11079408
This study is all about making better medicines for kids who are at risk for HIV and related infections, so they can have safe and effective treatments to help them stay healthy.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ADVANCED BIOSCIENCE LABORATORIES, INC. (nih funded) |
| Locations | 1 site (KENSINGTON, UNITED STATES) |
| Trial ID | NIH-11079408 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and improving drug formulations specifically for pediatric patients, particularly those at risk for HIV and related infections. The project aims to support the development of new therapeutic and preventive products through collaboration with academic and private sector partners. By providing essential resources and materials, the research seeks to advance promising drug candidates into clinical testing, ensuring that they are safe and effective for young patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include children aged 0-11 years who are at risk for HIV or related infections.
Not a fit: Patients outside the age range of 0-11 years or those not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective HIV prevention and treatment options tailored for children, improving their health outcomes.
How similar studies have performed: Previous research has shown success in developing pediatric formulations for other conditions, indicating potential for similar advancements in HIV prevention.
Where this research is happening
KENSINGTON, UNITED STATES
- ADVANCED BIOSCIENCE LABORATORIES, INC. — KENSINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SILVERA, PETER — ADVANCED BIOSCIENCE LABORATORIES, INC.
- Study coordinator: SILVERA, PETER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus